Statements (18)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:alsoKnownAs |
Poly IC:LC
|
gptkbp:CASNumber |
31852-29-6
|
gptkbp:chemicalClass |
synthetic double-stranded RNA
|
gptkbp:clinicalTrialPhase |
gptkb:Phase_I
Phase II |
gptkbp:developedBy |
Oncovir, Inc.
|
https://www.w3.org/2000/01/rdf-schema#label |
Hiltonol
|
gptkbp:mechanismOfAction |
TLR3 agonist
|
gptkbp:routeOfAdministration |
subcutaneous
intravenous intranasal |
gptkbp:usedFor |
immunostimulant
|
gptkbp:usedIn |
vaccine
immunotherapy infectious disease research |
gptkbp:bfsParent |
gptkb:Oncovir
|
gptkbp:bfsLayer |
8
|